In vitro biological activities of niloticane, a new bioactive cassane diterpene from the bark of Acacia nilotica subsp. kraussiana

Journal of Ethnopharmacology

Volumn 128, Issue 3, 2010, Pages 555-560

  Eldeen, I M S ^a   Van Heerden, F R ^a   Van Staden, J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Acacia nilotica subsp. kraussiana; Acetylcholinesterase inhibitory activity; Antibacterial activity; Inhibition of prostaglandin biosynthesis

Indexed keywords

ACETYLCHOLINESTERASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DITERPENE; GALANTAMINE; INDOMETACIN; NEOMYCIN; NILOTICANE; UNCLASSIFIED DRUG;

ACACIA; ACACIA NILOTICA; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; ENZYME INHIBITION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ACACIA; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACILLUS SUBTILIS; BIOLOGICAL ASSAY; CASCARA; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; CYCLOOXYGENASE 1; DITERPENES; ESCHERICHIA COLI; ETHNOPHARMACOLOGY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MEDICINE, AFRICAN TRADITIONAL; MICROBIAL SENSITIVITY TESTS;

ACACIA NILOTICA; BACILLUS SUBTILIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 77951209244     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.01.057     Document Type: Article

References (34)

1. Adami A., Coppelli G., Guaita E., Pozzoli C., Menozzi A., Giovannini E., Coruzzi G. Effects of cyclooxygenase-1 and -2 inhibition on gastric acid secretion and cardiovascular functions in rats. Pharmacology 2006, 76:84-92.
2. Clements J.M., Coignard F., Johnson I., Chandler S., Palan S., Waller A., Wijkmans J., Hunter M.G. Antibacterial activities and characterization of novel inhibitors of LpxC. Antimicrobial Agents and Chemotherapy 2002, 46:1793-1799.
3. Cowan M.M. Plant products as antimicrobial agents. Clinical Microbiology Review 1999, 12:564-582.
4. Daniel M. Impediments preventing India becoming a herbal giant. Current Science 2004, 87:275-276.
5. Dickson R.A., Houghton P.J., Hylands P.J. Antibacterial and antioxidant cassane diterpenoids from Caeslpinia benthamiana. Phytochemistry 2007, 68:1436-1441.
6. Eldeen I.M.S., Elgorashi E.E., Van Staden J. Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. Journal of Ethnopharmacology 2005, 102:457-464.
7. Eldeen I.M.S, Van Staden J. In vitro pharmacological investigation of extracts from some trees used in Sudanese traditional medicine. South African Journal of Botany 2007, 73:435-440.
8. Ellman G.L., Courtney D., Andies V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961, 7:88-95.
9. Eloff J.N. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica 1998, 64:711-713.
10. Howes M.-J., Houghton P.J. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacology, Biochemistry and Behavior 2003, 75:513-527.
11. Hutchings A., Scott A.H., Lewis G., Cunningham A.B. Zulu Medicinal Plants. An Inventory 1996, University of Natal Press, Pietermaritzburg.
12. Jäger A.K., Hutchings A., Van Staden J. Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors. Journal of Ethnopharmacology 1996, 52:95-100.
13. Joshi K.C., Bansal R.K., Sharma T., Murray R.D.H., Forbes I.T., Cameron A.F., Maltz A. Two novel cassane diterpenoids from Acacia jacquemontii. Phytochemistry 1979, 35:1449-1453.
14. Kitamura T., Kauwamori T., Uchiya N., Itoh M., Noda T., Matsuura M., Sugimura T., Wakabayashi K. Inhibitory effects of mofezolac, acyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis. Carcinogenesis 2002, 23:1463-1466.
15. Koga J., Shimura M., Oshima K., Ogawa N., Yamauchi T., Ogasawara N. Phytocassanes A, B, C and D, novel diterpene phytoalexins from rice, Oryza sativa L. Tetrahedron 1995, 51:7907-7918.
16. Kulkarni S.K., Jain N.K., Singh A. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors. Methods and Findings in Experimental and Clinical Pharmacology 2000, 22:291-298.
17. Lee I.S., Jin W.Y., Zhang X., Hung T.M., Song K.S., Seong Y.H., Bae K. Cytotoxic and COX-2 inhibitory constituents from the Arial parts of Aralia cordata. Archive Pharmacological Research 2006, 29:548-555.
18. Lin A.-S., Lin C.-R., Du Y.-C., Lübken T., Chiang M.Y., Chen I.-H., Wu C.-C., Hwang T.-L., Chen S.-L., Yen M.-H., Chang F.R., Wu Y.-C. Acasiane A and B and farnesirane A and B, diterpene derivatives from the root of Acacia farnesiana. Planta Medica 2009, 75:256-261.
19. Loftin C.D., Trivedi D.B., Langenbach R. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus. The Journal of Clinical Investigation 2002, 110:549-557.
20. Matsuno Y., Deguchi J., Hosoya T., Hirasawa Y., Hirobe C., Shiro M., Morita H. Sucutiniranes C-F, cassane-type diterpenes from Bowdichia nitida. Journal of Natural Products 2009, 72:976-979.
21. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
22. National Institute of Allergy Infectious Diseases Understanding Microbes in Sickness and in Health 2006, NIH, (publication no. 06-4914).
23. Nguyen H.M., Graber C.J. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?. Journal of Antimicrobial Chemotherapy 2009, 377:1-13. 10.1093/jac/dkp.
24. Noreen Y., Ringborm T., Perera P., Danielson H., Bohlin L. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. Journal of Natural Products 1998, 61:2-7.
25. Paiott A.P.R., Neto R.A., Forones N.M., Oshima C.T.F., Miszputen S.J., Franco M. Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis. Brazilian Journal of Medical and Biological Research 2007, 40:911-918.
26. Rhee I.K., Van De Meent M., Ingkaninan K., Verpoorte R. A screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. Journal of Chromatography A 2001, 915:217-223.
27. Rhee I.K., Van Rijn R.M., Verpoorte R. Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin-layer chromatography. Phytochemical Analysis 2003, 14:127-131.
28. Van Kiem P., Minh C.V., Huong H.T., Lee J.J., Kim Y.H. Caesaldecan, a cassane diterpenoid from the leaves of Caesalpinia decapetala. Chemical and Pharmaceutical Bulletin 2005, 53:428-430.
29. Van Wyk B., Van Wyk P. Field Guide to Trees of Southern Africa 1997, Struik Publishers (a Division of New Holland Publishing South Africa), Cape Town, South Africa, p. 496.
30. Venter F., Venter J.-A. Making the Most of Indigenous Trees 2002, Briza Publications, Pretoria, South Africa, p. 28. rev. edition.
31. Watt J.M., Breyer-Brandwijk M.G. The Medicinal and Poisonous Plants of Southern and East Africa 1962, E and S Livingstone Ltd., London, pp. 53-54.
32. Yadav P.P., Maurya R., Sarkar J., Arora A., Kanojiya S., Sinha S., Sristava M.N., Raghubir R. Cassane diterpenoids from Caesalpinia bonduc. Phytochemistry 2009, 70:256-261.
33. Zangara A. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacology, Biochemistry and Behavior 2003, 75:675-686.
34. Zschocke S., Van Staden J. Cryptocarya species-substitute plants for Ocotea bullata? A pharmacological investigation in terms of cyclooxygenase-1 and -2 inhibition. Journal of Ethnopharmacology 2000, 71:473-478.